January 10, 2018 – The Tuberculosis Trials Consortium (TBTC) is a global leader in research and development for better tools to prevent, diagnose, and treat tuberculosis (TB). Housed within the U.S. Centers for Disease Control and Prevention (CDC), the TBTC conducts clinical…
Note that the following PDFs listed at the top of this page were handouts shared with the Webinar: --Phase III Clinical Trial Results at the 48th Union World Conference on Lung Health: Implications for the Field1, PDF --TB CAB's Proposed…
On October 12, 2017, in Guadalajara, Mexico, Treatment Action Group, Advanced Access & Delivery, Harvard Medical School, Partners In Health, and the Stop TB Partnership sponsored a symposium in conjunction with the Union World Conference on Lung Health. Introduction -…
TAG participated in a hearing in Geneva, Switzerland to brief members of the Human Rights Council on human rights concerns in the United Arab Emirates (UAE).
Remarks by Erica Lessem, Deputy Executive Director – TB Project Global Ministerial Conference on Ending TB in the Sustainable Development Era Moscow, Russian Federation November 17, 2017 Using lessons learnt from HIV, how do you see civil society and advocacy…
Global funding for tuberculosis (TB) research reached a previously unreported high of $726 million in 2016, according to a report released today by Treatment Action Group (TAG) and the United Nations–hosted Stop TB Partnership.
The world spent $726 million on tuberculosis (TB) research in 2016, marking the first time annual spending has exceeded $700 million since TAG began tracking funding in 2005. Although this figure is $105 million above 2015 levels, it remains woefully inadequate when judged against the innovation gaps holding back the TB response and the ambitious global goals to end the TB epidemic by 2030.
TAG comments submitted to the Strategic Planning Team at the Office of the Assistant Secretary for Planning and Evaluation regarding the HHS Strategic Plan FY 2018-2022. The HHS Strategic Plan should set a precedent for reducing the burden of disease nationally through its focus on access to affordable treatment, advancement of research, implementation of evidence-based interventions, expansion of populations served, and inclusion of all stakeholders.
The United Nations High Level Meeting (HLM) on TB is rapidly approaching. The U.N. HLM on TB will take place on September 26, 2018 during the second day of general debate of the General Assembly at its seventy-third session…
TAG and partners hosted this webinar on October 3, 2017. Speakers included Lynette Mabote, AIDS & Rights Alliance for Southern Africa; Lindiwe Mvusi, Department of Health, Republic of South Africa; Stephen Wanjala, MSF; and Wayne van Gemert, Global Drug Facility…